We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Non Allergenic Type of Latex Glove Available

By HospiMedica staff writers
Posted on 06 May 2008
A new patient examination glove is made from a new form of natural rubber latex derived from the guayule bush Parthenium argentatum, a desert plant native to the Southwestern United States.

The Yulex patient examination glove was developed for people who are highly allergic to traditional latex. More...
The natural guayule latex is an alterative to synthetics and does not contain the tropical proteins that cause potentially life-threatening reactions in people with Type 1 latex allergy. In addition to their low levels, guayule proteins did not cross-react with the antibodies to tropical proteins in trials involving animal and humans. These trials included Dr. H's blood test, western blot analysis, ELISA (enzyme-linked immunosorbent assay), skin-prick tests, and in vitro RAST (radioallergosorbent assay) assays. The gloves are an effective barrier to human viruses and can be stored for years without the deterioration of their barrier capabilities. The Yulex guayule films show slightly higher tensile strength than tropical natural latex films or nitrile synthetic latex films. The Yulex films exceed American Society for Testing and Materials (ASTM) standards for surgical gloves and are 33% stronger than synthetic polyisoprene latex films.

The Yulex patient examination glove is made by the Yulex (Maricopa, AZ, USA), and has been approved by the U.S. Food and Drug Administration (FDA). However, since there is no long-term experience data with the Yulex glove, the product will carry a warning regarding the possibility of allergic reactions.

"This approval has the potential to make a significant difference to both the general public and the medical community at large,” said Daniel Schultz, M.D., director of FDA's center for devices and radiological health. "Gloves made from guayule latex may prove to be a safer alternative for some people with sensitivity to traditional latex. And yet they will not sacrifice the desirable properties of traditional latex such as flexibility and strength.”

Between 3% and 22% of all health care workers are sensitized to traditional latex gloves made from the milky sap of a rubber tree Hevea braziliensis, the sap of which contains a protein that may trigger allergic reactions, especially after prolonged and repeated contact. Sensitized people may experience mild reactions such as skin redness, rash, hives, or itching. More severe reactions may include respiratory symptoms such as difficulty breathing, coughing spells, and wheezing. Rarely, shock may occur.


Related Links:
Yulex

Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Head Rest
Medifa 61114_3
Surgical Headlight
IsoTorch
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The researchers grew pancreatic tissue (above) so it incorporated a mesh-like electronic network (red). Cells within the tissue produce insulin (green). (Photo courtesy of Penn Medicine)

‘Cyborg’ Transplants Could Replace Pancreatic Tissue Damaged by Diabetes

Type 1 diabetes destroys insulin-producing islet cells, forcing patients to rely on lifelong insulin therapy or scarce organ transplants. Although lab-grown pancreatic tissue offers a promising alternative,... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.